But most are concerned about AI-related skill loss. Healthcare leaders need guardrails and training so doctors use AI daily without eroding their core skills.

Structure Therapeutics' pill matches Novo’s and Lilly’s on weight loss, teeing up fiercer competition.

Their ad budgets are shifting from linear TV to digital channels like CTV and social media, but big TV events still garner significant spending.

A Massachusetts judge halts recent vaccine recommendation changes, boosting medical professionals' sway with parents and patients—for now.

Most consumers give health apps a try, but just 3% stay after 30 days. AI features may be the fix, but only if brands don't overhype their value.

AI prep is changing visits, with doctors wary of misinformation but optimistic about patient education.

Americans across income brackets are cutting spending, rationing meds, and delaying surgery to pay for healthcare costs.

Lilly’s new safety allegations add fuel to lawsuits and FDA actions targeting telehealth sellers of compounded weight loss drugs.

Tighter Medicare Advantage oversight may force insurers to cut perks, exit markets, and leave seniors navigating pricier plans.

The AI portal ties health records and wearables together as daily health conversations top 50 million.

Novo drops court fights to secure GLP-1 distribution, which will drive other telehealth brands to weigh pharma deals against legal risk.

Standalone telemental health solutions could benefit from health systems' pursuit of online players that drive referrals.

After White House autism claims, acetaminophen use fell 10% before rebounding, showing how fast trust can waver.

Its $100 million acquisition brings compliant conversations to life sciences CRM amid rising AI adoption.

Many act on their advice—even over doctors’—reshaping how young consumers make decisions about healthcare.

Even with deep discounts, sharper digital marketing will be needed to raise awareness among cash-pay patients.

Steady telehealth use among patients supports many market players, but winners will pair Rx access with user experience, AI, and caring providers.

85% of healthcare orgs plan to boost agentic AI spending and expect near-term savings. Amazon has the technical edge, but may face an uphill battle against entrenched healthcare vendors.

CVS' new Health100 is designed to let consumers—even outside CVS’ network—manage their health more efficiently through tech. But industry adoption may lag.

It rolled out a direct-to-employer payment model aimed at expanding weight loss drug access at work with flat pricing.